For patients with acute ischemic stroke due to large-vessel occlusion who present within 4.5 hours, intravenous tenecteplase ...

Administering tenecteplase before endovascular therapy improves outcomes in large vessel occlusion stroke treated within 4.5 ...

Intravenous tenecteplase bridging boosted the benefit of endovascular thrombectomy for acute ischemic stroke patients who ...

The MERCI®retrieval device and the Penumbra Stroke System®are US FDA-approved endovascular devices for thrombectomy in acute ischemic stroke due to cerebral vascular occlusions. Widespread ...

Findings from the Chinese randomized trial support what most centers in the US are already doing, one expert says.

Fernandez is board-certified and holds Focused Practice Designation in CNS endovascular surgery. She uses minimally invasive ...

Strokes remain one of the world’s biggest killers. Thrombectomy offers renewed hope, especially when supported by ...

Route 92 Medical, Inc. announced FDA 510(k) clearance (product code: NRY) for the company’s HiPoint reperfusion system, which ...

The TESLA trial was unable to support a benefit to thrombectomy for stroke patients with large-core infarcts identified on noncontrast CT within 24 hours. Unlike other studies, endovascular ...

Treatment with endovascular thrombectomy did not significantly improve outcomes after 90 days in patients with a large core stroke, as compared to patients who received standard stroke care alone ...